Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Clinical trial NCT03601507 · TERMINATED

Trial details

NCT number: NCT03601507
Sponsor: University of Arizona
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

CDKN2A-p16 Positive HPV Positive Oropharyngeal Squamous Cell Carcinoma Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

Start date: 2019-03-11
Primary completion: 2022-05-24
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.